EMAARDEV:DFMEmaar Development PJSC Analysis
Data as of 2026-03-14 - not real-time
AED 13.30
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Emaar Development is trading at a deep discount to its intrinsic valuation, with the current price of 13.3 AED versus a DCF fair value of roughly 70.6 AED, implying a potential upside of over 50%. The stock sits just above a key support level of 13.25 AED and is in an oversold condition, as indicated by an RSI of 21, while the 20‑day SMA (17.9) remains well above both the 50‑day (17.1) and 200‑day (14.7) averages, suggesting a longer‑term bullish bias. Volume is on an increasing trend, providing liquidity for a rebound, even though the MACD shows a bearish histogram. Fundamentals are exceptionally strong: revenue grew 47.6% YoY, gross margin sits near 56%, operating margin near 50%, and ROE is a robust 37%. The company’s balance sheet is ultra‑conservative with a debt‑to‑equity of just 3.8% and cash reserves exceeding AED 41 bn, while the payout ratio of 24% supports a generous 7.5% dividend yield. Valuation multiples are historically low (PE 4.7× vs industry average 32.5×, PB 1.43×), reinforcing the case for undervaluation. Market sentiment is currently in “Greed” mode (fear‑greed index 72.9), yet price momentum remains modest. The combination of high cash flow, low leverage, and strong earnings growth positions the stock favorably for both capital appreciation and dividend income. However, the 30‑day volatility of roughly 53% and a beta under 0.6 highlight notable price swings. In summary, the stock presents a compelling upside thesis anchored by solid fundamentals, attractive yield, and a massive valuation gap, but investors should be mindful of short‑term volatility and the need for price confirmation above support.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI indicating near‑term price rebound potential
- Support level at 13.25 AED providing a safety cushion
- Increasing volume confirming market interest
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of >50% versus current market price
- Strong revenue growth and high operating margins
- Attractive 7.5% dividend yield with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained low leverage and abundant cash reserves
- Robust ROE and consistent earnings generation
- Potential sector cyclicality that may temper price gains
Key Metrics & Analysis
Financial Health
Revenue Growth47.60%
Profit Margin41.17%
P/E Ratio4.7
ROE37.33%
ROA11.95%
Debt/Equity0.04
P/B Ratio1.4
Op. Cash FlowAED21.0B
Free Cash FlowAED6.5B
Industry P/E32.5
Technical Analysis
TrendBullish
RSI21.6
SupportAED 13.25
ResistanceAED 20.10
MA 20AED 17.91
MA 50AED 17.06
MA 200AED 14.69
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueAED 70.63
Target PriceAED 20.28
Upside/Downside52.46%
GradeUndervalued
TypeGrowth
Dividend Yield7.52%
Risk Assessment
Beta0.55
Volatility52.97%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.